Supply Chain | April 17, 2026
DKSH and Sanofi join forces to expand access to cardio & diabetes treatments in Southeast Asia
The aim is to bolster healthcare delivery in a region increasingly burdened by chronic disease
The aim is to bolster healthcare delivery in a region increasingly burdened by chronic disease
Acquires 85% stake in the formulations company valued at Rs 200 crore enterprise value; founder Vivek Seth to retain 15%
Former Wavemaker executive to lead media strategy and digital transformation agenda
The collaboration combines Alveus’ expertise in metabolic biology and therapeutic strategy with Aurigene’s integrated discovery capabilities
The event marks a significant push into South Korea’s rapidly expanding bio-health ecosystem
The companies plan to advance multiple solid tumor targets from Regeneron’s antibody portfolio
Arcot is a seasoned executive with more than two decades of experience across the global pharma and life sciences sectors
Exclusive distribution pact with Amcor broadens access to Parafilm M sealing solutions for laboratories, horticulture and industrial users
CDSCO-approved therapy enters India’s fast-growing post-patent GLP-1 market with fully integrated API, formulation and pen manufacturing
The programme features headline data from pivotal Phase III trials, including PREVAIL in gMG, KOMET in NF1-PN, and CHAMPION-NMOSD, alongside real-world evidence supporting established therapies
Subscribe To Our Newsletter & Stay Updated
